Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors



Rating:

Share or cite this content

Citations should be made in the following way:
H. Snène (Tunis, Tunisia), W. Fenina (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), M. Maalej (Tunis, Tunisia), I. El Wadhane (Tunis, Tunisia), A. Jebali (Tunis, Tunisia), A. Laater (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia). Characteristics of COVID-19 infection in diabetics. 811

Member's Comments

No comment yet.

Related content which might interest you: Incidence and clinical characteristics of tuberculosis in diabetic patients Source: Eur Respir J 2006; 28: Suppl. 50, 506s Year: 2006 Characteristics of tuberculosis patients co-infected with COVID-19 Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Comparative study of community-acquired pneumonia between diabetic and nondiabetic patients with hyperglycemia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Comparative study of community acquired pneumonia in diabetes mellitus patients Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort Source: Eur Respir J 2016; 48: 264-268 Year: 2016 Prevalence of virus infections in patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 599s Year: 2004 Comparison of the epidemiological radio-clinical and evolutive profile of pulmonary tuberculosis in diabetic patients and non diabetic ones Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Peculiarities of tuberculosis in HIV-infected subjects Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Impact of diabetes mellitus on microbiological profiles of patients with community-acquired pneumonia in a central hospital Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Characteristics and predictors of mortality in patients with pleural infection Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Prognosis value of hypertension in Covid-19 infection Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Adults without HIV infection hospitalised for tuberculosis – Clinical and drug sensitivity profiles Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Particularities of pneumonia in diabetes patients. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Undiagnosed diabetes mellitus in community-acquired pneumonia - A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Characteristics of hospitalized COVID-19 patients and parameters associated with severe pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021